The FDA has used drugs to boost pain relief, boost sleep and ease anxiety in patients who suffer from chronic pain.
The FDA announced on Thursday that it is using an opioid to treat pain for people with a range of chronic conditions including pain, migraines, Crohn’s disease and rheumatoid arthritis.
The drug, Xanax, was approved by the FDA in February for people who suffer with chronic pain and have a high level of tolerance to the drug.
The drug, also known as “xanax,” was developed by the National Institutes of Health and has been approved by other countries including the U.K. and Switzerland.
“The Xanax program has been designed to deliver these beneficial effects to patients who have been treated with opioid analgesics, but there are some limitations with the drug, which is known to cause severe, debilitating withdrawal symptoms,” said Dr. Timothy Coyle, chief medical officer of Pfizer Inc., the drugmaker that developed Xanax.
The new medication is being used in the U, Australia, the U of A and others to treat severe, persistent pain caused by a variety of conditions including arthritis, cancer, multiple sclerosis, fibromyalgia, chronic pain, multiple organ failure, multiple trauma, multiple infections, osteoarthritis and multiple sclerosis.
It’s also being used to treat insomnia and anxiety, which are among the other conditions the drug has been tested on.
The drugs are approved by a federal panel of experts and have undergone extensive clinical trials.
The Drug Enforcement Administration said Xanax and other opioids are being prescribed in some of the country’s most restrictive states, including Texas, New York and Alabama.
The agency said Xanox is being prescribed to treat patients who are already on opioids.